Effect of Hepatic Impairment on LDK378 Pharmacokinetics
NCT01950481
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Normal Hepatic Function
Impaired Hepatic Function
Interventions
DRUG:
LDK378
Sponsor
Novartis Pharmaceuticals